+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma



Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma



Iranian Journal of Basic Medical Sciences 19(10): 1131-1135



Similar characteristics of molecular pathways between cellular reprogramming events and tumorigenesis have been accentuated in recent years. Reprogramming-related transcription factors, also known as Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC), are also well-known oncogenes promoting cancer initiation, progression, and cellular transformation into cancer stem cells. Long non-coding RNAs (lncRNAs) are a major class of RNA molecules with emerging roles in stem cell pluripotency, cellular reprogramming, cellular transformation, and tumorigenesis. The long intergenic non-coding RNA ROR (lincRNA-ROR, linc-ROR) acts as a regulator of cellular reprograming through sponging miR-145 that normally negatively regulates the expression of the stemness factors NANOG, OCT4, and SOX2. Here, we employed a real-time PCR approach to determine the expression patterns of linc-ROR and its two novel spliced variants (variants 2 and 4) in esophageal squamous cell carcinoma (ESCC). The quantitative real-time RT-PCR results revealed a significant up-regulation of linc-ROR (P=0.0098) and its variants 2 (P=0.0250) and 4 (P=0.0002) in tumor samples of ESCC, compared to their matched non-tumor tissues obtained from the margin of same tumors. Our data also demonstrated a significant up-regulation of variant 4 in high-grade tumor samples, in comparison to the low-grade ones (P=0.04). Moreover, the ROC curve analysis demonstrated that the variant 4 of ROR has a potential to discriminate between tumor and non-tumor samples (AUC=0.66, P<0.05). Our data suggest a significant up-regulation of linc-ROR and its variants 2 and 4 in ESCC tissue samples.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058219291

Download citation: RISBibTeXText

PMID: 27872710


Related references

Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9. Journal of Experimental and Clinical Cancer Research 36(1): 182, 2017

Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma. Journal of BUON 23(1): 157-162, 2018

NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma. Diseases of the Esophagus 23(8): 675-681, 2010

Krüppel-like factor 9 was down-regulated in esophageal squamous cell carcinoma and negatively regulated beta-catenin/TCF signaling. Molecular Carcinogenesis 55(3): 280-291, 2016

Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma. Journal of Surgical Oncology 97(1): 44-50, 2008

Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. Bmc Cancer 9: 426, 2009

Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World Journal of Gastroenterology 18(7): 712-719, 2012

Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. Anticancer Research 29(4): 1233-1241, 2009

Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World Journal of Surgery 36(1): 90-97, 2012

Candidate susceptibility variants for esophageal squamous cell carcinoma. Genes Chromosomes and Cancer 56(6): 453-459, 2017

Two novel variants on 13q22.1 are associated with risk of esophageal squamous cell carcinoma. Cancer Epidemiology Biomarkers and Prevention 24(11): 1774-1780, 2015

MiR-150 regulates the EMT-inducer ZEB1 in esophageal squamous cell carcinoma. Wound healing assays of premiR-150-treated esophageal squamous cell carcinoma TE-8 cells. Cancer Science 104(1): January Cover-January Cover, 2013

HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc. Tumour Biology 35(5): 4123-4129, 2014

A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. Annals of Oncology 29(4): 938-944, 2018

Overexpression of periostin is significantly correlated to the tumor angiogenesis and poor prognosis in patients with esophageal squamous cell carcinoma. International Journal of Clinical and Experimental Pathology 7(2): 593-601, 2014